CTMX Operating Income - CytomX Therapeutics, Inc.

Complete source-backed operating income history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$23.78M
2026-03-31	-$19.67M
2025-12-31	-$27.93M
2025-09-30	-$15.77M
2025-06-30	-$1.29M
2025-03-31	$22.62M
2024-12-31	$17.68M
2024-09-30	$4.11M
2024-06-30	-$8.45M
2024-03-31	$11.66M
2023-12-31	-$606,000.00
2023-09-30	$3.12M
2023-06-30	-$3.35M
2023-03-31	-$5.65M
2022-12-31	-$9.51M
2022-09-30	-$29.71M
2022-06-30	-$30.05M
2022-03-31	-$32.06M
2021-12-31	-$58.57M
2021-09-30	-$22.64M
2021-06-30	-$19.21M
2021-03-31	-$15.63M
2020-12-31	-$14.78M
2020-09-30	-$14.9M
2020-06-30	-$16.14M
2020-03-31	-$2.79M
2019-12-31	-$37.38M
2019-09-30	-$25.72M
2019-06-30	-$31.23M
2019-03-31	-$16.57M
2018-12-31	-$25.81M
2018-09-30	-$23.18M
2018-06-30	-$13.26M
2018-03-31	-$15.63M
2017-12-31	-$1.25M
2017-09-30	-$11.03M
2017-06-30	-$25.37M
2017-03-31	-$8.61M
2016-12-31	-$14.23M
2016-09-30	-$14.92M
2016-06-30	-$14.26M
2016-03-31	-$16.18M
2015-12-31	-$11.52M
2015-09-30	-$11.27M
2015-06-30	-$5.54M
2015-03-31	-$4.87M
2014-12-31	-$4.66M
2014-09-30	-$3.46M

Annual Operating Income

Date	Operating Income
2025-12-31	-$22.36M
2024-12-31	$25M
2023-12-31	-$6.48M
2022-12-31	-$101.34M
2021-12-31	-$116.04M
2020-12-31	-$48.61M
2019-12-31	-$110.9M
2018-12-31	-$77.87M
2017-12-31	-$46.26M
2016-12-31	-$59.59M
2015-12-31	-$33.2M
2014-12-31	-$29.77M
2013-12-31	-$14.96M